Ascend Wellness Holdings, Inc. (AAWH) stock
AAWHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.39−0.00 (-0.73%)
Close on Oct 19, 2026Market cap $79.60MP/E –Yield –
Ascend Wellness operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Ascend Wellness's operating income for the twelve months ending Jun 30, 2026 was -$10.67M, down 306.6% year over year. For fiscal 2025 it was -$17.01M, down 459.4% from the year before. The highest annual figure on record is $7.85M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$17.01M | -459.4% |
| FY2024 | Dec 31, 2024 | $4.73M | – |
| FY2023 | Dec 31, 2023 | -$3.62M | – |
| FY2022 | Dec 31, 2022 | -$7.53M | – |
| FY2021 | Dec 31, 2021 | -$17.20M | -319.2% |
| FY2020 | Dec 31, 2020 | $7.85M | – |
| FY2019 | Dec 31, 2019 | -$26.12M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.28M | – |
| Q1 FY2026 | Mar 31, 2026 | $2.55M | +2.4% |
| Q4 FY2025 | Dec 31, 2025 | -$17.17M | -381.6% |
| Q3 FY2025 | Sep 30, 2025 | -$1.33M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.00M | – |
| Q1 FY2025 | Mar 31, 2025 | $2.49M | -3.5% |
| Q4 FY2024 | Dec 31, 2024 | $6.10M | +981.2% |
| Q3 FY2024 | Sep 30, 2024 | -$2.42M | -168.1% |
| Q2 FY2024 | Jun 30, 2024 | -$1.52M | – |
| Q1 FY2024 | Mar 31, 2024 | $2.58M | +909.8% |
| Q4 FY2023 | Dec 31, 2023 | $564.00K | -89.5% |
| Q3 FY2023 | Sep 30, 2023 | $3.55M | +43.2% |
| Q2 FY2023 | Jun 30, 2023 | -$7.99M | – |
| Q1 FY2023 | Mar 31, 2023 | $255.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $5.38M | – |
| Q3 FY2022 | Sep 30, 2022 | $2.48M | -78.7% |
| Q2 FY2022 | Jun 30, 2022 | -$605.00K | -115.5% |
| Q1 FY2022 | Mar 31, 2022 | -$14.78M | – |
| Q4 FY2021 | Dec 31, 2021 | -$731.00K | -116.4% |
| Q3 FY2021 | Sep 30, 2021 | $11.61M | +246.4% |
| Q2 FY2021 | Jun 30, 2021 | $3.90M | +77.2% |
| Q1 FY2021 | Mar 31, 2021 | -$31.99M | – |
| Q4 FY2020 | Dec 31, 2020 | $4.45M | – |
| Q3 FY2020 | Sep 30, 2020 | $3.35M | – |
| Q2 FY2020 | Jun 30, 2020 | $2.20M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.16M | – |
See a number that looks wrong?